** Shares of CSPC Pharmaceutical Group 1093.HK jump 12.3% to HK$8.56, their highest since March 2023
** Stock set for the biggest one-day pct rise since November 2022; top pct gainer in the Hang Seng Index .HSI
** CSPC said it is in negotiations with independent third parties on three transactions involving license, collaboration in development, manufacturing and commercialization of certain products with upfront payments amounting to an aggregate $5 bln
** Hong Kong's healthcare index .HSCIH climbs 0.5%, Hang Seng Biotech Index .HSHKBIO gains 0.8%
** YTD, stock up 72.4%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。